摘要 |
The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders. |
申请人 |
BAYER PHARMA AKTIENGESELLSCHAFT |
发明人 |
KNORR, ANDREAS;WUNDER, FRANK;KÖBBERLING, JOHANNES;LERCHEN, HANS-GEORG;FLAMME, INGO;REDLICH, GORDEN;GRIEBENOW, NILS;SCHONE-LOOP, RUDOLF;WITTROCK, SVEN;KOLLNBERGER, MARIA;MARLEY, JULY;PRITCHARD, IAIN |